Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 6

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 6
---
 relating to the sale of these shares. We have agreed to pay the legal, accounting, printing, and other
expenses related to the registration of the sale of the Shares of Common Stock in this Offering. All of the net proceeds from the sale
of the Shares in the Resale Offering by the Selling Stockholder will go to the Selling Stockholders. However, to the extent that the Investor
Warrants held by the Selling Stockholders are exercised for cash, we will receive payment of the exercise price in connection with such
exercise.

Investing in our securities involves a high degree of risk. You should invest in our securities only if you can afford to lose your entire investment. you should read and carefully consider risks described in the “ Risk Factors” section beginning on page 5 of this prospectus.

You should rely only
on the information contained in this prospectus or any prospectus supplement or amendment thereto. We have not authorized anyone to provide
you with different information.

The information in this Prospectus is not complete and may be changed. This Prospectus is included in the registration statement that was filed by Revium Rx. with the Securities and Exchange Commission. The Selling Stockholders may not sell these Shares until the registration statement becomes effective. This Prospectus is not an offer to sell these Shares and is not soliciting an offer to buy these Shares in any State where the offer or sale is not permitted.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this Prospectus is ____________, 2025

TABLE OF CONTENTS</div>

|                                                                                                    |     | Page |
| About This Prospectus                                                                              |     |   ii |
| Prospectus Summary                                                                                 |     |    1 |
| Summary of the Offering                                                                            |     |    4 |
| Risk Factors                                                                                       |     |    5 |
| Special Note About Forward-Looking Statements                                                      |     |   30 |
| Use of Proceeds                                                                                    |     |   31 |
| Determination of the Offering Price                                                                |     |   32 |
| Capitalization                                                                                     |     |   33 |
| Dilution                                                                                           |     |   34 |
| Market Price of and Dividends on the Company’s Common Equity                                       |     |   35 |
| Management’s Discussion and Analysis of Financial Condition and Results of